"There have been many changes recently in the treatment of hematological and hemato-oncological diseases in Poland. However, not all needs have been met - this includes shortening the length of the diagnostic and therapeutic path followed by patients, increasing the number of medical staff and pricing of diagnostic procedures."

– prof. dr. hab. n. med. Iwona Hus, President of the Polish Society of Hematologists and Transfusionologists

 

"The improvement of the patients' situation was influenced not only by new therapies, but also by rearranging existing drug programs, which required really hard work from many experts. Also this year, molecules intended for this group of oncology patients appeared on the reimbursement lists. Even on the last list - in July reimbursement system, we also have modern drug technologies that save the lives of patients with light chain amyloidosis, multiple myeloma and Waldenström's macroglobulinemia.

– Krystyna Wechmann, President of the Polish Coalition of Oncology Patients

 

We encourage you to read the materials, including: on: leukemias, lymphomas, anemia, the situation of a hematological patient, multiple myeloma or Waldenström's macroglobulinemia.

 

All materials are available on the website www.eksperciozdrowieu.pl.